Neurobiological Tech (NTII) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurobiological Tech (NTII)

NTII 0.0001000

0.0%

Mar 7 3:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (65)	1/21/1997 4:47:00 AM
From: NANCY JEWETT	of 1494

Richard, I am hoping for every reason for a good outcome for this trial. I am frightened at the thought of a double-blind, placebo controlled study on patients with such serious symptoms. How can anyone facing these symptoms be expected to not do everything they can to get the real drug and not the placebo? How hard can it be to tell a milk pill from a drug? Is this an IV administration? Hopefully the drug will be found effective if it really is in spite of the difficulties of these trials, and somehow the survival issues will be resolved quickly. I am not sure that stock price is the most interesting issue here, although I hope at least to not lose my shirt. Best to all!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next